TrialNature medicine2023

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.

Tina Cascone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.